Benefits and pitfalls encountered in psychiatric genetic association studies

Biological Psychiatry

Volumn 45, Issue 5, 1999, Pages 544-550

  Malhotra, Anil K ^a   Goldman, David ^b  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Allele; Association; Gene; Genetics; Polymorphism; Psychiatry

Indexed keywords

ALLELE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME; MENTAL DISEASE; PERSONALITY DISORDER; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

ALLELES; GENE EXPRESSION; GENETIC TECHNIQUES; GENOTYPE; HUMANS; MENTAL DISORDERS; PHENOTYPE; POLYMORPHISM, GENETIC; VARIATION (GENETICS);

EID: 0033106068     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00365-5     Document Type: Review

References (48)

1. Allikmets R, Singh N, Sun H, Shroyer NF, Hutchinson A, Chidambaram A, et al (1997): A photoreceptor cell-specific ATP-binding transporter gene (ACBR) is mutated in recessive Stargardt macular dystrophy. Nature Genet 15:236-246.
2. 2A receptor gene. Lancet 346:281-282.
3. Benjamin J, Greenberg B, Murphy DL, Lin L, Patterson C, Hamer DH (1996): Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking. Nature Genet 12:81-84.
4. Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, Jagadeeswaran P, et al (1990): Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA 263:2055-2060.
5. Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA (1993): Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262(5133):578-580.
6. Burmeister M (1999): Basic Concepts in the study of diseases with complex genetics. Biol Psychiatry 45:522-532.
7. Chang FM, Kidd JR, Livak KJ, Pakstis AJ, Kidd KK (1996): The world-wide distribution of allele frequencies at the human dopamine D4 receptor locus. Hum Genet 98(1):91-101.
8. Chee M, Yang R, Hubbell E, Berno A, Huang XC, Stern D, et al (1996): Accessing genetic information with high-density DNA arrays. Science 274:610-614.
9. Cook EH, Courchesne R, Lord C, Cox NJ, Yan S, Lincoln A, et al (1997): Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry 2:224-226.
10. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, et al (1996): Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273:1856-1862.
11. Freedman R, Coon H, Myles-Worsley M, Orr-Urtreger A, Olincy A, Davis A (1997): Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci 94(2):587-592.
12. Gejman PV, Ram A, Gelernter J, Friedman E, Cao Q, Pickar D, et al (1994): No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. JAMA 271: 204-208.
13. Gershon ES, Badner JA, Goldin LR, Sanders AR, Cravchik A, Detera-Wadleigh SD (1998): Closing in on genes for manic-depressive illness and schizophrenia. Neuropsychopharmacology 18:233-242.
14. Goedde HW, Agarwal DP, Fritze G, Meier-Tackmann D, Singh S, Beckmann G (1992): Distribution of ADH2 and ALDH2 genotypes in different populations. Hum Genet 88(3):344-346.
15. Goldman D, Brown GL, Albaugh B, Robin R, Goodson S, Trunzo M, et al (1993): DRD2 dopamine receptor genotype, linkage disequilibrium and alcoholism in American Indians and other populations. Alcohol Clin Exp Res 17:199-204.
16. Goldman D, Urbanek M, Guenther D, Robin R, Long UC (1997): The dopamine D2 receptor: Linkage and association of a functional allele [Ser311Cys] and other D2DR markers to alcoholism, substance abuse and schizophrenia in Southwestern American Indians. Neuropsychiatric Genetics 74:386-394.
17. Grandy DK, Litt M, Allen L, Bunzow JR, Marchionni M, Makam H (1989): The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am J Hum Genet 45(5):778-785.
18. Gusella JF, Wezler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE, et al (1983): A polymorphic DNA marker genetically linked to Huntington's disease. Nature 306(5940): 234-238.
19. Harada S, Agarwal DP, Goedde HW (1981): Aldehyde dehydrogenase deficiency as cause of facial flushing reaction to alcohol in Japanese. Lancet 2(8253):982.
20. Hauser P, Zametkin AJ, Martinez P, Vitiello B, Matochik JA, Mixson AJ, et al (1993): Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormone. N Engl J Med 328(14):997-1001.
21. Kittles RA, Perola M, Peltonen L, Bergen AW, Virkkunen M, Linnoila M, et al (in press): Y chromosome microsatellite variation in Finland reveals two distinct founding lineages. Am J Hum Genet.
22. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al (1996): Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531.
23. Long JC, Williams RC, Urbanek M (1995): An E-M algorithm and testing strategy for multiple-locus haplotypes. Am J Hum Genet 56(3):799-810.
24. Malhotra AK, Goldman D, Mazzanti C, Clifton A, Breier A, Pickar D (1998): A functional serotonin transporter (5-HTT) polymorphism is associated with psychosis in neuroleptic-free schizophrenics. Mol Psychiatry 3:328-332.
25. 2A receptor gene and the antipsychotic response to clozapine. Am J Psychiatry 153:1092-1094.
26. 23Ser polymorphism. NeuroReport 7:2100-2102.
27. Masellis M, Paterson AD, Badri F, Lieberman JA, Meltzer HY, Cavazzoni P, et al (1995): Genetic variation of 5-HT2A receptor and response to clozapine. Lancet 346:1108.
28. Mazzanti CM, Lappalainen J, Long J, Bengel D, Naukkarinen H, Eggert M, et al (in press): Role of the serotonin transporter promoter polymorphism in anxiety related traits. Arch Gen Psychiatry.
29. Nguyen TV, Kosofsky BE, Birnbaum R, Cohen BM, Hyman SE (1992): Differential expression of c-fos and zip268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc Natl Acad Sci 89(10):4270-4274.
30. Nothen MM, Rietschel M, Erdmann J, Oberlander H, Moller HJ, Naber D, et al (1995): Genetic variation of the 5-HT2A receptor and response to clozapine. Lancet 346:908-909.
31. Myers RM, Fischer SG, Lerman LS, Maniatis T (1985): Nearly all single base substitutions in DNA fragments joined to a GC-clamp can be detected by denaturing gradient gel electrophoresis. Nucleic Acids Res 13:3131-3145.
32. Orita M, Suzuki Y, Seyiya T, Hayashi K (1989): Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5(4): 874-879.
33. Ott J (1985): Analysis of human genetic linkage. Johns Hopkins University Press.
34. Pauling L, Itano HA, Singer SJ, Wells IC (1949): Sickle cell anemia: A molecular disease. Science 110:543.
35. Plomin R, Owen MJ, McGuffin P (1994): The genetic basis of complex human behaviors. Science 264:1733-1739.
36. Risch N, Merikangas K (1996): The future of genetic studies of complex human diseases. Science 273:1516-1517.
37. Rosenthal NE, Mazzanti CM, Barnett RL, Hardin TA, Turner EH, Lam GK, et al (1998): Role of serotonin transporter promoter repeat length polymorphism (5-HTTEPR) in seasonality and seasonal affective disorder. Mol Psychiatry 3:175-177.
38. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, et al (1996): Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722-725.
39. Seegmiller JE, Rosenbloom FM, Kelley WN (1967): Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis. Science 155:1682-1684.
40. Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, et al (1997): Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 277:959-965.
41. Sodhi MS, Arranz MJ, Curtis D, Ball DM, Sham P, Roberts GW, et al (1995): Association between clozapine response and allelic variation in the 5-HT2C receptor gene. NeuroReport 7:169-172.
42. Spielman RS, Ewens WJ (1996): The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet 59:983-989.
43. Templeton AR, Boerwinkle E, Sing CF (1987): A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping. I. Basic theory and an analysis of alcohol dehydrogenase activity in Drosophila. Genetics 117(2):343-351.
44. Terwilliger J, Ott J (1992): A haplotype-based "Haplotype Relative Risk" approach to detecting allelic associations. Hum Hered 42:337-346.
45. Tsui LC, Buchwald M, Barker D, Braman JC, Knowlton R, Schumm JW, et al (1985): Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker. Science 230(4729):1054-1057.
46. Underbill PA, Jin L, Lin AA, Medhi SQ, Jenkins T, Vollrath D, et al (1997): Detection of numerous Y chromosome biallelic polymorphisms by denaturing high-performance liquid chromatography. Genome Res 7(10):996-1005.
47. Williams J, Spurlock G, Holmans P, Mant R, Murphy K, Jones L, et al (1998): A meta-analysis and transmission disequilibrium study of association between the dopamine D3 receptor gene and schizophrenia. Mol Psychiatry 3:141-149.
48. Winkler C, Modi W, Smith MW, Nelson GW, Wu X, Carrington M, et al (1998): Genetic restriction of AIDS pathogenesis by an SDF1 chemokine gene mutation. Science 279:389-393.